Insider Selling: Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider Sells 68,547 Shares of Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider David K. Morris sold 68,547 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $1,381,907.52. Following the completion of the transaction, the insider now directly owns 214,495 shares in the company, valued at $4,324,219.20. The trade was a 24.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Guardian Pharmacy Services Stock Performance

Guardian Pharmacy Services stock traded up $0.49 during trading hours on Tuesday, reaching $21.78. 290,686 shares of the company's stock were exchanged, compared to its average volume of 169,453. The firm's 50 day simple moving average is $23.19 and its 200 day simple moving average is $22.01. Guardian Pharmacy Services, Inc. has a twelve month low of $14.16 and a twelve month high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analysts' expectations of $321.21 million. As a group, analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on GRDN shares. Wall Street Zen downgraded Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Truist Financial reaffirmed a "buy" rating and set a $28.00 target price (up from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th. Finally, Raymond James set a $28.00 target price on Guardian Pharmacy Services and gave the stock an "outperform" rating in a research report on Wednesday, May 14th.

Institutional Trading of Guardian Pharmacy Services

Large investors have recently made changes to their positions in the company. GAMMA Investing LLC acquired a new stake in shares of Guardian Pharmacy Services in the 1st quarter valued at about $170,000. R Squared Ltd acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at about $30,000. BNP Paribas Financial Markets acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at about $37,000. Compass Financial Services Inc acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at about $58,000. Finally, JPMorgan Chase & Co. acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at about $77,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.